Compare Amphastar Pharmaceuticals Inc (AMPH) vs Extra Space Storage, Inc. (EXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Extra Space Storage, Inc. — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M), while Extra Space Storage, Inc. trades at $146.41 (market cap $30.98B). The key difference: Extra Space Storage, Inc. is far larger — about 35.9× Amphastar Pharmaceuticals Inc's market cap, and Extra Space Storage, Inc. pays a 4.42% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | EXR | |
|---|---|---|
Market Cap | $863.95M | $30.98B |
Sector | Health | Real Estate |
52-Week High | $30.81 | $152.85 |
52-Week Low | $16.87 | $126.67 |
Enterprise Value | $1.26B | $44.70B |
Dividend Yield | — | 4.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.
Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.
EXR trades at $149.54, near its 52-week high, with a bullish technical outlook supported by moving averages and strong earnings beats in recent quarters. The company reported Q2 2026 core FFO of $2.15 per share, exceeding estimates, and raised full-year guidance. Revenue growth remains steady, with a net income margin of 27.79% in 2025, though valuation ratios like P/E of 33.01 suggest a premium pricing.
Outlook is positive with analyst consensus price target of $157.25, but risks include high debt levels and competitive pressures in the self-storage sector. The stock offers a dividend yield supported by solid cash flows, making it attractive for income-focused investors amid cautious market sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Extra Space Storage, Inc.
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages almost 2,100 self-storage properties in 41 states, with over 160 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
Read more on EXR →
